皮肤被浸润性癌累犯，直接扩散。
The skin is involved by invasive carcinoma by direct extension.
附属的骨骼肌被浸润性癌累犯，直接扩散。
The attached skeletal muscle is involved by invasive carcinoma by direct extension.
但没有任何临床研究能证实这些病变与浸润性癌相同。
But there are no any clinical study to confirm these lesions are the same as invasive ca.
本例的局灶性区域可见小的单个腺体，形似于浸润性癌。
In focal areas of this case, there are small individual glands, which may mimic invasive carcinoma.
只有那些没有浸润性癌残留，有完全病理缓解的病人才作为最后的标本分析。
A patient was considered to have had a complete pathologic response if no residual invasive cancer was present on final specimen analysis.
浸润性癌如idc是较严重的乳腺癌，约站所有乳腺癌的70- 80%。
Invasive cancers such as IDC are more serious and account for 70-80 percent of all breast cancers.
尽管目前的外科手术技术以及围绕手术结合化疗等医疗技术水平有所提高，但浸润性癌患者的预后仍相当差。
The prognosis of patients with advanced bladder cancer is still extremely poor despite recent therapeutic advances, such as improved surgical techniques and perioperative combination chemotherapy.
胆管癌早期即可通过淋巴、胆管壁及神经途径转移，浸润性生长是其主要病理学特点。
ObjectiveCholangiocarcinoma may metastasis via lymphatic, bile duct and nerve at early stage, infiltrating growth is its major feature of Pathology.
在这个试验中，入选标准为年龄大于45岁经历保乳手术的浸润性导管癌的患者。
In this trial, women aged at least 45 years with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled.
肝细胞癌(HCC)是最常见的恶性肿瘤之一，由于快速浸润性生长及合并肝硬化因此其预后不良。
Hepatocellular carcinoma (HCC) is one of the most common malignancies. It has a poor prognosis due to its rapid infiltrating growth and complicated liver cirrhosis.
膀胱癌的复发性和浸润性是影响治疗预后的主要原因。
Both invasion and recurrence are the major reasons that limited the therapeutic prognosis of bladder cancer.
高倍在纤维间质中可见浸润性小叶癌癌细胞单行排列的特征性病变。多形性不大。
At high magnification, the characteristic "Indian file" strands of infiltrating lobular carcinoma cells are seen in the fibrous stroma. Pleomorphism is not great.
事实上，最近的结果表明，基因疗法可以用于治疗致命性的浸润性脑癌。
Indeed, recent results suggest that gene therapy can be beneficial for patients suffering from aggressive brain cancer that would otherwise be lethal.
那么，是什么亚型的浸润性小叶癌呢？
目的：报道9例浸润性膀肤癌患者在术前加用双侧骼内动脉灌注化疗，对其疗效进行观察分析。
Purpose: 9 patients with invasive bladder cancer were treated with preoperative chemotherapy of internal iliac intra -artery, and the curative effect is evaluated.
病理类型以浸润性非特殊型癌为主。
The major pathological type was infiltrative non specific cancer.
用免疫组化技术检测了15例正常口腔粘膜、45例癌前病变和21例浸润性鳞癌标本的P53蛋白的表达。
P53 protein expression was studied with immunohistochemically in 15normal oral mucosas, 45 precancerous lesions and 21 invasive squamous cell carcinomas.
同时看到导管内癌与浸润性导管癌。
Both intraductal and infiltrating ductal carcinoma are seen here.
一般认为，浸润性宫颈癌的治疗是手术和放疗。
In general, for invasive carcinoma of uterine cervix, the treatment is surgery and radiotherapy.
高倍在纤维间质中可见浸润性小叶癌癌细胞列兵样排列的特征性病变。
At high magnification, the characteristic "Indian file" strands of infiltrating lobular carcinoma cells are seen in the fibrous stroma.
目的：评估髂内动脉灌注化疗联合放疗治疗浸润性膀胱癌的有效性及安全性。
Objective: To evaluate the efficacy of bladder sparing treatment by internal iliac arterial infusion chemotherapy and radiotherapy in invasive bladder carcinoma.
结论？肿瘤组织的血管生成在卵巢癌的浸润性生长及转移方面起着重要作用，MVD可作为判断恶性卵巢肿瘤预后的一项重要指标。
Conclusions? Tumor angiogenesis plays an important role in tumor invasion and metastasis. MVD may serve as a significant prognostic indicator in EOC.
术后病理2例伴有部分恶变，1例对侧为浸润性小叶癌。
Postoperative pathological findings revealed 2 cases of partial malignant change and 1 case of contralateral infiltrating lobular carcinoma.
浸润性小叶癌的表现缺乏特征性。
The invasive lobular carcinoma didn't show any characteristic findings.
左边典型的浸润性导管癌与右边良性纤维腺瘤的肉眼特征的近距离比较。
Here is a side by side comparison of the gross characteristics of a classic infiltrating ductal carcinoma on the left and a benign fibroadenoma on the right.
不同组织学类型TAM抑制率实验似有差异，髓样癌的阳性检出率较浸润性导管癌高。
The TAM positive rate in medullary cancer was higher than that in other pathologic types of breast tumors and it was the lowest in ductal cancers.
导管内癌（或伴早浸）与浸润性导管癌相比，表达水平低，差异有显著性意义（P<0.05）。
There was also significant difference between ductal carcinoma in situ (or with early infiltration) and invasive ductal carcinoma (P<0.05), and the former was weaker.
导管内癌（或伴早浸）与浸润性导管癌相比，表达水平低，差异有显著性意义（P<0.05）。
There was also significant difference between ductal carcinoma in situ (or with early infiltration) and invasive ductal carcinoma (P<0.05), and the former was weaker.
应用推荐